{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,8]],"date-time":"2026-04-08T11:01:48Z","timestamp":1775646108364,"version":"3.50.1"},"reference-count":12,"publisher":"BMJ","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/bmj.com\/coronavirus\/usage"}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2020,7,1]]},"published-print":{"date-parts":[[2020,7]]},"abstract":"<jats:p>Originating from Wuhan, China, COVID-19 has rapidly spread worldwide. Neurological manifestations are more commonly associated with severe COVID-19 infection. Guillain-Barr\u00e9 syndrome (GBS) is a rare immune-mediated postinfectious neuropathy. It has been reported as a possible rare complication of COVID-19. We report a case of GBS associated with COVID-19 in the UK.<\/jats:p>","DOI":"10.1136\/bcr-2020-236536","type":"journal-article","created":{"date-parts":[[2020,7,9]],"date-time":"2020-07-09T02:15:20Z","timestamp":1594260920000},"page":"e236536","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":43,"title":["Guillain-Barr\u00e9 syndrome associated with COVID-19 infection: a case from the UK"],"prefix":"10.1136","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3183-7087","authenticated-orcid":false,"given":"May Yung","family":"Tiet","sequence":"first","affiliation":[{"name":"Department of Neurology, University Hospitals of Leicester NHS Trust, Leicester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nazar","family":"AlShaikh","sequence":"additional","affiliation":[{"name":"Department of Neurology, University Hospitals of Leicester NHS Trust, Leicester, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2020,7,8]]},"reference":[{"key":"2025082704034196000_13.7.e236536.1","doi-asserted-by":"crossref","unstructured":"Mao L , Wang M , Chen S , et al . Neurological manifestations of hospitalized patients with COVID-19 in Wuhan, China: a retrospective case series study. SSRN Journal 2020.doi:10.2139\/ssrn.3544840","DOI":"10.2139\/ssrn.3544840"},{"key":"2025082704034196000_13.7.e236536.2","doi-asserted-by":"crossref","DOI":"10.1016\/j.tmaid.2020.101642","article-title":"Sars-Cov-2: underestimated damage to nervous system","volume":"101642","author":"Zhou","year":"2020","journal-title":"Travel Med Infect Dis"},{"key":"2025082704034196000_13.7.e236536.3","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1056\/NEJMc2008597","article-title":"Neurologic features in severe SARS-CoV-2 infection","volume":"382","author":"Helms","year":"2020","journal-title":"N Engl J Med Overseas Ed"},{"key":"2025082704034196000_13.7.e236536.4","doi-asserted-by":"crossref","unstructured":"Toscano G , Palmerini F , Ravaglia S , et al . Guillain\u2013Barr\u00e9 syndrome associated with SARS-CoV-2 To. NEJM, 2020.","DOI":"10.1056\/NEJMc2009191"},{"key":"2025082704034196000_13.7.e236536.5","doi-asserted-by":"crossref","unstructured":"Riva N , Russo T , Falzone YM , et al . Post-Infectious Guillain\u2013Barr\u00e9 syndrome related to SARS-CoV-2 infection: a case report. J Neurol 2020:1\u20133.doi:10.1007\/s00415-020-09907-z","DOI":"10.1007\/s00415-020-09907-z"},{"key":"2025082704034196000_13.7.e236536.6","doi-asserted-by":"crossref","unstructured":"Chan JL , Ebadi H , Sarna JR . Guillain-Barr\u00e9 syndrome with facial diplegia related to SARS-CoV-2 infection. Can J Neurol Sci 2020:1\u20133.doi:10.1017\/cjn.2020.106","DOI":"10.1017\/cjn.2020.106"},{"key":"2025082704034196000_13.7.e236536.7","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(20)30109-5"},{"key":"2025082704034196000_13.7.e236536.8","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awt285"},{"key":"2025082704034196000_13.7.e236536.9","unstructured":"Lin E . COVID-19 \u2013 Associated Miller Fisher Syndrome\u202f: MRI Findings, 2020: 1\u20133."},{"key":"2025082704034196000_13.7.e236536.10","doi-asserted-by":"crossref","unstructured":"Andrea A , Luana B , Silvia DM , et al . New clinical manifestation of COVID-19 related Guillain-Barr\u00e8 syndrome highly responsive to intravenous immunoglobulins: two Italian cases. Neurol Sci 2020:1\u20134.doi:10.1007\/s10072-020-04484-5","DOI":"10.1007\/s10072-020-04484-5"},{"key":"2025082704034196000_13.7.e236536.11","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1001\/jama.2020.2783","article-title":"Positive RT-PCR test results in patients recovered from COVID-19","volume":"323","author":"Lan","year":"2020","journal-title":"JAMA"},{"key":"2025082704034196000_13.7.e236536.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijid.2020.03.062"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2020-236536","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T11:03:49Z","timestamp":1756292629000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2020-236536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7]]},"references-count":12,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2020,7,8]]},"published-print":{"date-parts":[[2020,7]]}},"alternative-id":["10.1136\/bcr-2020-236536"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2020-236536","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7]]}}}